13th Annual Biomarker Congress

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 55 presentations, case studies, round-table and panel discussions focused on the key innovations of biomarker research in discovery and development, companion diagnostics, data management, innovative biology, precision medicine and clinical biomarkers.

6 Interactive Streams:

• Biomarkers in Drug Discovery & Development – Therapeutic areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology
• Personalised Medicine, Companion Diagnostics and Development
• Biomarker Discovery, Verification & Validation, and Safety – Therapeutic areas: Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome
• Innovations in Biomarkers Research, Assay Development, Imaging, Data Management
• Biomarker in Clinical Development & Clinical Trials
• Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development